124. Leukemia and beyond: Next-gen precision cell therapy, Ivan Dimov, Co-Founder & CEO, Orca Bio
Synopsis: Ivan Dimov is the Co-Founder and CEO of Orca Bio, a cell therapy company focusing on next-generation precision cell therapies for blood cancer patients. Orca Bio’s cell therapies are design...
26 Okt 202224min
123. Nano-rare patients & rare diseases, Stanley Crooke, Founder & CEO, n-Lorem Foundation
Synopsis: Stanley Crooke is Founder and CEO of n-Lorem Foundation, a nonprofit with the goal of discovering, developing and providing experimental ASO treatments to nano-rare patients for free for li...
19 Okt 202234min
122. New vision for cell & gene therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp
Synopsis: Andrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp, a cell and gene therapy technology company powering transformative therapies. They join ...
12 Okt 202220min
121. Mission-driven biotech investing, Josh Wolfe, Co-founder & Managing Partner, Lux Capital
Synopsis: Josh Wolfe is the Co-Founder and Managing Partner of Lux Capital, a venture capital firm that invests in emerging science and technology ventures. Josh joins us for a discussion centered ar...
5 Okt 202227min
120. Beyond CD8 immuno-oncology, Amanda Wagner, President and CEO, Immunitas Therapeutics
Amanda Wagner is the President and CEO of Immunitas and was a founding member of the company at its launch in 2019. During her time at Immunitas, she has contributed to the company’s fundraising effor...
28 Sep 202223min
119. Special Edition: Quiet Leader, Loud Results, Ankit Mahadevia, Author
Interested in purchasing the book? Order here: https://amzn.to/3R4RWfT Ankit Mahadevia is the founder and CEO of Spero Therapeutics, an organization committed to fighting the threat of infectious dis...
21 Sep 202211min
118. One team, one mission: tackling pruritus, Chris Posner, President & CEO, Cara Therapeutics
Christopher Posner Chief Executive Officer, President, and Director Mr. Posner has served as our President and Chief Executive Officer since November 2021 and has served as a member of our Board sinc...
14 Sep 202234min
117. Pioneering cell biology drug discovery, Rachel Meyers, CSO, Faze Medicines
Rachel Meyers serves as the chief scientific officer at Faze Medicines. She was most recently an entrepreneur-in-residence at Third Rock Ventures (TRV), where she helped drive the creation of Faze Me...
31 Aug 202223min
